FDA
approval
· 2023-08-31
FDA Approved: LEVETIRACETAM — Supplemental Application (Prasco Laboratories)
Summary
FDA indicates a Supplemental Application for Levetiracetam submitted by Prasco Laboratories; this represents an additional regulatory action related to the prod…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for LEVETIRACETAM (LEVETIRACETAM)